Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-15-358139
Filing Date
2015-10-29
Accepted
2015-10-29 17:16:15
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d47737ds3.htm S-3 263477
2 EX-4.10 d47737dex410.htm EX-4.10 33239
3 EX-4.11 d47737dex411.htm EX-4.11 355663
4 EX-4.12 d47737dex412.htm EX-4.12 35493
5 EX-4.13 d47737dex413.htm EX-4.13 392781
6 EX-5.1 d47737dex51.htm EX-5.1 28885
7 EX-12.1 d47737dex121.htm EX-12.1 21942
8 EX-23.1 d47737dex231.htm EX-23.1 2421
  Complete submission text file 0001193125-15-358139.txt   1135015
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-207670 | Film No.: 151184619
SIC: 2835 In Vitro & In Vivo Diagnostic Substances